Kymera Therapeutics, Inc. (KYMR)
82.21
-2.29
(-2.71%)
USD |
NASDAQ |
May 15, 16:00
82.23
+0.02
(+0.02%)
After-Hours: 20:00
Kymera Therapeutics Price : 82.21 for May 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 129.58 |
| Revolution Medicines, Inc. | 145.66 |
| Catalyst Pharmaceuticals, Inc. | 31.18 |
| Regeneron Pharmaceuticals, Inc. | 698.25 |
| AbbVie, Inc. | 210.39 |
Price Related Metrics
| PS Ratio | 141.82 |
| PEG Ratio | -1.513 |
| Price to Book Value | 4.392 |
| Earnings Yield | -4.34% |
| Market Cap | 6.762B |
| PEGY Ratio | -1.513 |